Coronary microvascular dysfunction and ischemia in hypertrophic cardiomyopathy. Mechanisms and clinical consequences

Iacopo Olivotto, Franco Cecchi, Paolo G. Camici

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Symptoms and signs of myocardial ischemia are often found in patients with hypertrophic cardiomyopathy (HCM) despite angiographically normal coronary arteries. Myocardial ischemia is deemed responsible for some of the lethal complications of HCM including ventricular arrhythmias, sudden death, progressive left ventricular remodeling, and systolic dysfunction. In the past decade, a number of studies using positron emission tomography have demonstrated severe impairment of the vasodilator response to dipyridamole in the majority of HCM patients, not only in the hypertrophied septum but also in the non-hypertrophied left ventricular free wall. In the absence of coronary stenoses, this finding is indicative of diffuse microvascular dysfunction, in line with the autoptic evidence of widespread abnormalities of the intramural coronary arterioles. In turn, microvascular dysfunction represents a very likely substrate for recurrent ischemia. This may account for the fact that microvascular dysfunction has recently been shown to represent an early and powerful predictor of an unfavorable outcome in HCM. The aim of this article is to provide a concise overview of the available evidence of microvascular dysfunction and ischemia in HCM, and to speculate on the potential implications for management.

Original languageEnglish
Pages (from-to)572-580
Number of pages9
JournalItalian Heart Journal
Volume5
Issue number8
Publication statusPublished - Aug 2004

Fingerprint

Hypertrophic Cardiomyopathy
Ischemia
Myocardial Ischemia
Ventricular Remodeling
Dipyridamole
Coronary Stenosis
Arterioles
Sudden Death
Vasodilator Agents
Positron-Emission Tomography
Signs and Symptoms
Cardiac Arrhythmias
Coronary Vessels

Keywords

  • Coronary microcirculation
  • Hypertrophic cardiomyopathy
  • Myocardial ischemia
  • Positron emission tomography

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Coronary microvascular dysfunction and ischemia in hypertrophic cardiomyopathy. Mechanisms and clinical consequences. / Olivotto, Iacopo; Cecchi, Franco; Camici, Paolo G.

In: Italian Heart Journal, Vol. 5, No. 8, 08.2004, p. 572-580.

Research output: Contribution to journalArticle

@article{a7997c11080d4b0dbce5d476ab5bac16,
title = "Coronary microvascular dysfunction and ischemia in hypertrophic cardiomyopathy. Mechanisms and clinical consequences",
abstract = "Symptoms and signs of myocardial ischemia are often found in patients with hypertrophic cardiomyopathy (HCM) despite angiographically normal coronary arteries. Myocardial ischemia is deemed responsible for some of the lethal complications of HCM including ventricular arrhythmias, sudden death, progressive left ventricular remodeling, and systolic dysfunction. In the past decade, a number of studies using positron emission tomography have demonstrated severe impairment of the vasodilator response to dipyridamole in the majority of HCM patients, not only in the hypertrophied septum but also in the non-hypertrophied left ventricular free wall. In the absence of coronary stenoses, this finding is indicative of diffuse microvascular dysfunction, in line with the autoptic evidence of widespread abnormalities of the intramural coronary arterioles. In turn, microvascular dysfunction represents a very likely substrate for recurrent ischemia. This may account for the fact that microvascular dysfunction has recently been shown to represent an early and powerful predictor of an unfavorable outcome in HCM. The aim of this article is to provide a concise overview of the available evidence of microvascular dysfunction and ischemia in HCM, and to speculate on the potential implications for management.",
keywords = "Coronary microcirculation, Hypertrophic cardiomyopathy, Myocardial ischemia, Positron emission tomography",
author = "Iacopo Olivotto and Franco Cecchi and Camici, {Paolo G.}",
year = "2004",
month = "8",
language = "English",
volume = "5",
pages = "572--580",
journal = "Italian Heart Journal",
issn = "1129-471X",
publisher = "Societa Italiana di Cardiologia",
number = "8",

}

TY - JOUR

T1 - Coronary microvascular dysfunction and ischemia in hypertrophic cardiomyopathy. Mechanisms and clinical consequences

AU - Olivotto, Iacopo

AU - Cecchi, Franco

AU - Camici, Paolo G.

PY - 2004/8

Y1 - 2004/8

N2 - Symptoms and signs of myocardial ischemia are often found in patients with hypertrophic cardiomyopathy (HCM) despite angiographically normal coronary arteries. Myocardial ischemia is deemed responsible for some of the lethal complications of HCM including ventricular arrhythmias, sudden death, progressive left ventricular remodeling, and systolic dysfunction. In the past decade, a number of studies using positron emission tomography have demonstrated severe impairment of the vasodilator response to dipyridamole in the majority of HCM patients, not only in the hypertrophied septum but also in the non-hypertrophied left ventricular free wall. In the absence of coronary stenoses, this finding is indicative of diffuse microvascular dysfunction, in line with the autoptic evidence of widespread abnormalities of the intramural coronary arterioles. In turn, microvascular dysfunction represents a very likely substrate for recurrent ischemia. This may account for the fact that microvascular dysfunction has recently been shown to represent an early and powerful predictor of an unfavorable outcome in HCM. The aim of this article is to provide a concise overview of the available evidence of microvascular dysfunction and ischemia in HCM, and to speculate on the potential implications for management.

AB - Symptoms and signs of myocardial ischemia are often found in patients with hypertrophic cardiomyopathy (HCM) despite angiographically normal coronary arteries. Myocardial ischemia is deemed responsible for some of the lethal complications of HCM including ventricular arrhythmias, sudden death, progressive left ventricular remodeling, and systolic dysfunction. In the past decade, a number of studies using positron emission tomography have demonstrated severe impairment of the vasodilator response to dipyridamole in the majority of HCM patients, not only in the hypertrophied septum but also in the non-hypertrophied left ventricular free wall. In the absence of coronary stenoses, this finding is indicative of diffuse microvascular dysfunction, in line with the autoptic evidence of widespread abnormalities of the intramural coronary arterioles. In turn, microvascular dysfunction represents a very likely substrate for recurrent ischemia. This may account for the fact that microvascular dysfunction has recently been shown to represent an early and powerful predictor of an unfavorable outcome in HCM. The aim of this article is to provide a concise overview of the available evidence of microvascular dysfunction and ischemia in HCM, and to speculate on the potential implications for management.

KW - Coronary microcirculation

KW - Hypertrophic cardiomyopathy

KW - Myocardial ischemia

KW - Positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=16644377705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16644377705&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 572

EP - 580

JO - Italian Heart Journal

JF - Italian Heart Journal

SN - 1129-471X

IS - 8

ER -